Evolving Market Trends In The Oral Proteins And Peptides Industry: Breakthrough Oral Insulin Technologies In Diabetes Care

The Oral Proteins And Peptides Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Oral Proteins And Peptides Market Size During the Forecast Period?
The oral proteins and peptides market size is projected to grow from $1.27 billion in 2024 to $1.56 billion in 2025 at a CAGR of 22.7%. The growth is attributed to the rising prevalence of chronic diseases, increasing investments in biotechnology for oral protein treatments, consumer preference for non-invasive treatments, the expanding biopharmaceutical industry, and a focus on personalized medicine.

The oral proteins and peptides market size is expected to grow to $3.49 billion in 2029 at a CAGR of 22.3%. Growth is driven by a focus on patient-centric drugs, aging populations, rising healthcare expenditures, cancer diagnostics, and preference for oral drugs. Key trends include the development of novel oral peptides, AI integration in drug discovery, advanced drug delivery technologies, and oral insulin formula

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19629

What Are the High-Growth Segments in the Oral Proteins And Peptides Market?
The oral proteins and peptidesmarket covered in this report is segmented -

1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide
2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets
3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action
4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer

Subsegments:
1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)
2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment
3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations
4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)
5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19629&type=smp

What Key Drivers Are Expected to Influence Future Oral Proteins And Peptides Market Growth?
The expanding biopharmaceutical industry is expected to drive the growth of the oral proteins and peptides market. The biopharmaceutical industry focuses on developing drugs from biological sources, with increasing demand for personalized medicine and advancements in biotechnology. Oral proteins and peptides offer an alternative to injections, improving patient compliance and targeting specific diseases. In June 2023, the European Federation of Pharmaceutical Industries and Associations reported a growth of about 4.95% in biopharmaceutical production in Europe. Therefore, the growth of the biopharmaceutical industry is propelling the oral proteins and peptides market.

Which Companies Hold the Largest Share Across Different Oral Proteins And Peptides Market Segments?
Major companies operating in the oral proteins and peptides market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

What Are the Latest Developing Trends in the Oral Proteins And Peptides Market?
Companies in the oral proteins and peptides market are focusing on developing innovative products like Oral Semaglutide to improve patient comfort and adherence. Oral semaglutide, a novel medication for treating type 2 diabetes and obesity, was launched in January 2022 by Novo Nordisk India. Unlike the injectable version, this oral form of semaglutide offers more convenience for patients, marking a significant breakthrough in diabetes treatment and paving the way for potential oral insulin formulations in the future.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report

What Are the Emerging Geographies for The Oral Proteins And Peptides Market Growth?
North America was the largest region in the oral proteins and peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Oral Proteins And Peptides Market?
2. What is the CAGR expected in the Oral Proteins And Peptides Market?
3. What Are the Key Innovations Transforming the Oral Proteins And Peptides Industry?
4. Which Region Is Leading the Oral Proteins And Peptides Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.